Lymphadenopathy

ByJames D. Douketis, MD, McMaster University
Reviewed ByJonathan G. Howlett, MD, Cumming School of Medicine, University of Calgary
Reviewed/Revised Modified Mar 2026
v6625096
View Patient Education

Lymphadenopathy is palpable enlargement of one or more lymph nodes. Diagnosis is clinical. Treatment is of the causative disorder.

Lymph nodes are present throughout the body and may be superficial or deep. Particular collections of superficial lymph nodes are present in the neck, axillae, and inguinal region; a few small (< 1 cm) nodes often are palpable in those areas in healthy people.

Lymphadenopathy is the abnormal size, growth, or consistency of one or more lymph nodes (1). Often lymphadenopathy involves palpable enlargement (> 1 cm for most nodes, > 2 cm for inguinal lymph nodes). Lymphadenopathy may be:

  • Localized: When present in only one body area

  • Generalized: When present in 2 body areas

Lymphadenitis is lymphadenopathy with pain and/or signs of inflammation (eg, erythema [more subtle on dark skin], tenderness).

Other symptoms may be present depending on the underlying disorder.

General reference

  1. 1. Falk N, Joseph R, Dieujuste M. Lymphadenopathy: Evaluation and Differential Diagnosis. Am Fam Physician. 2025;112(3):286-293.

Pathophysiology of Lymphadenopathy

Some plasma and cells (eg, cancer cells, infectious microorganisms) in the interstitial space, along with certain cellular material, antigens, and foreign particles, enter lymphatic vessels and become constituents of lymphatic fluid. Lymph nodes filter the lymphatic fluid on its way to the central venous circulation, removing cells and other material. The filtering process also presents antigens to the lymphocytes contained within the nodes. The immune response from these lymphocytes involves cellular proliferation, which can cause the nodes to enlarge (reactive lymphadenopathy). Pathogenic microorganisms carried in the lymphatic fluid can directly infect the nodes, causing lymphadenitis, and cancer cells may lodge in and proliferate in the nodes.

Etiology of Lymphadenopathy

Because lymph nodes participate in the body's immune response, most causes of lymphadenopathy are infectious, inflammatory, or malignant (see table ). Only the more common causes are discussed here. Causes most likely vary depending on patient age, associated findings, and risk factors. Localized lymphadenopathy of short duration (< 2 weeks) is generally benign in both adults and children (1, 2). (An exception is localized supraclavicular or epitrochlear lymphadenopathy, which may herald cancer.)

Common causes of benign localized lymphadenopathy include:

  • Idiopathic, self-limited

  • Upper respiratory infections (URI)

  • Local soft-tissue infections

Localized lymphadenopathy lasting > 2 weeks is not always benign (eg, cervical lymphadenopathy in head and neck cancer; supraclavicular or epitrochlear lymphadenopathy in lymphoma or metastatic cancer).

Generalized lymphadenopathy suggests underlying systemic disease caused by infection (eg, infectious mononucleosis), malignancy (eg, lymphoma), or autoimmune disorders (eg, systemic lupus erythematosus).

Dangerous causesof lymphadenopathy include:

Approximately 1% of undifferentiated cases in adults presenting for primary care involve cancer, although this figure increases to 4% in patients over 40 years of age (1).

Table
Table

Etiology references

  1. 1. Falk N, Joseph R, Dieujuste M. Lymphadenopathy: Evaluation and Differential Diagnosis. Am Fam Physician. 2025;112(3):286-293.

  2. 2. Stanford EF, Levine HM, Cabana MD, Anosike BI. Lymphadenopathy: Differential Diagnosis and Indications for Evaluation. Pediatr Rev. 2024;45(8):429-439. doi:10.1542/pir.2023-006291

Evaluation of Lymphadenopathy

Adenopathy may be the patient's reason for presenting or be discovered during evaluation for another complaint.

History

History of present illness should determine the location and duration of adenopathy and whether it is accompanied by pain. Recent cutaneous injuries (particularly insect bites, cat scratches, and rat bites) and infections in the area drained by affected nodes are noted.

Review of systems should seek symptoms and signs of possible causes (see table ), including:

Past medical history should identify risk factors for (or known) TB or HIV infection, and cancer (particularly use of alcohol and/or tobacco). Patients are queried about contacts who are ill (to assess risk of TB or viral illnesses, such as Epstein-Barr virus) and sexual history (to assess risk of sexually transmitted infections).

Travel history should identify visits to areas of endemic infections (eg, Middle East for brucellosis, American Southwest for plague) and possible exposures (eg, cat feces for toxoplasmosis, farm animals for brucellosis, wild animals for tularemia). Medication history is reviewed for specific known causative agents.

Physical examination

Vital signs are reviewed for fever. Areas of particular lymph node concentration in the neck (including occipital and supraclavicular areas), supraclavicular, epitrochlear, and axillary, and inguinal regions are palpated. Node size, tenderness, and consistency are noted as well as whether the nodes are freely mobile or fixed to adjacent tissue.

Skin is inspected for rash and lesions, with particular attention to areas drained by the affected nodes. The oropharynx is inspected and palpated for signs of infection and any lesions that may be cancerous. The thyroid gland is palpated for enlargement and nodularity. Breasts (including in males) are palpated for lumps. Lungs are auscultated for crackles (suggesting sarcoidosis or infection). Abdomen is palpated for hepatomegaly and splenomegaly. Genitals are examined for chancres, vesicles, and other lesions, and for urethral discharge. Joints are examined for signs of inflammation.

Red flags

  • Cervical or inguinal node > 2 cm or any palpable supraclavicular or axillary node regardless of size

  • Node that is draining, hard, or fixed to underlying tissue

  • Risk factors for HIV or TB

  • Fever and/or weight loss

  • Splenomegaly

Interpretation of findings

Patients with generalized adenopathy often have a systemic disorder. However, patients with localized adenopathy may have a local or systemic disorder (including one that often causes generalized adenopathy).

Sometimes, history and physical examination suggest a cause (see table ) and may be diagnostic in patients with a clear viral upper respiratory infection or with local soft-tissue or dental infection. In other cases, findings (such as the red flag findings) are of concern but do not point to a single cause.

Cervical or inguinal nodes that are hard, markedly enlarged (generally > 2 cm, although inguinal nodes may reach 2 cm in healthy adults—[1]), and/or fixed to adjacent tissue are concerning for cancer, particularly in patients who have had prolonged use of tobacco and/or alcohol. However, any palpable supraclavicular or axillary node not ascribable to infection regardless of size, should prompt concern about possible intrathoracic or breast cancer. Marked tenderness, erythema, and warmth in a single enlarged node may be due to a suppurative node infection (eg, due to staphylococcus or streptococcus).

Fever may occur with many of the infectious, malignant, and systemic rheumatic disorders. Splenomegaly can occur with mononucleosis, toxoplasmosis, leukemia, and lymphoma. Weight loss occurs with TB and cancer. Risk factors and travel and exposure history are at best suggestive.

Finally, adenopathy can have a serious cause in patients who have no other manifestations of illness.

Testing

If a specific disorder is suspected (eg, mononucleosis in a young patient with fever, sore throat, and splenomegaly), initial testing is directed at clinically indicated tests for that condition (see table ). For example, patients with lymphadenopathy, joint symptoms and rash might undergo antinuclear antibody testing for systemic lupus erythematosus, and viral testing for acute HIV and parvovirus B19.

If history and physical examination do not show a likely cause, further evaluation depends on the nodes involved and the other findings present. Patients with newly identified localized or generalized adenopathy and no systemic symptoms, red flags, increased risk or suspicion of malignancy can safely be observed for up to 4 weeks, unless cancer is suspected (1).

Patients with unexplained red flag findings and those with generalized adenopathy should have a complete blood count (CBC) and chest radiograph (1). If abnormal white blood cells are seen on CBC, a peripheral smear and flow cytometry are performed to evaluate for leukemia or lymphoma. For generalized adenopathy of unclear etiology, a complete evaluation includes treponemal antibody, tuberculin skin test (or interferon-gamma release assay), serologic tests for HIV, hepatitis B surface antigen, antinuclear antibody, C-reactive protein, erythrocyte sedimentation rate, double-stranded DNA antibodies, anti-cyclic citrullinated peptide antibody, lactate dehydrogenase, and rheumatoid factors.

Imaging of localized lymphadenopathy often begins with ultrasound, especially in children ≤ 14 years of age (1, 2). Ultrasound can reveal size, extent, vascularity, and sometimes suggest a cause. Chest radiography can help in evaluation for suspected malignancy, as well as identify infectious causes in the case of cervical, thoracic, or generalized adenopathy. If cancer is suspected, or for adults and older adolescents (> 14 years) with persistent and unexplained lymphadenopathy, patients undergo computed tomography (CT) or magnetic resonance imaging (MRI) of the area as clinically indicated.

Depending on the findings and degree of suspicion for malignancy, patients should have biopsy of the node and any abnormal tissue. Biopsy is also considered if isolated or generalized adenopathy does not resolve in 3 to 4 weeks (3), or if a cause is not apparent despite a thorough diagnostic evaluation. Tissue can be obtained by fine needle aspirate, core needle biopsy, or excisional biopsy; core needle biopsy is a good initial choice (1).

Evaluation references

  1. 1. Falk N, Joseph R, Dieujuste M. Lymphadenopathy: Evaluation and Differential Diagnosis. Am Fam Physician. 2025;112(3):286-293.

  2. 2. Stanford EF, Levine HM, Cabana MD, Anosike BI. Lymphadenopathy: Differential Diagnosis and Indications for Evaluation. Pediatr Rev. 2024;45(8):429-439. doi:10.1542/pir.2023-006291

  3. 3. Bazemore AW, Smucker DR. Lymphadenopathy and malignancy. Am Fam Physician 2002;66(11):2103-2110.

Treatment of Lymphadenopathy

Primary treatment is directed at the cause; adenopathy itself is not treated.

A trial of glucocorticoids is not done for adenopathy of unknown etiology because glucocorticoids can reduce adenopathy caused by leukemia and lymphoma and thus delay diagnosis (1), and glucocorticoids can exacerbate TB.

A trial of antibiotics is also not generally indicated, except when a suppurative lymph node infection is suspected.

Treatment reference

  1. 1. Falk N, Joseph R, Dieujuste M. Lymphadenopathy: Evaluation and Differential Diagnosis. Am Fam Physician. 2025;112(3):286-293.

Key Points

  • Most lymphadenopathy is idiopathic and self limited or results from clinically apparent local causes.

  • Initial testing should be performed if there are red flag findings, if other manifestations or risk factors suggest a specific disorder, or when generalized adenopathy has no apparent cause.

  • Patients with newly identified localized or generalized lymphadenopathy and no other diagnostic findings can be observed for up to 4 weeks, after which time a more extensive diagnostic evaluation, potentially including biopsy, should be considered.

quizzes_lightbulb_red
Test your KnowledgeTake a Quiz!
IOS ANDROID
IOS ANDROID
iOS ANDROID